Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Target-specific compound selectivity for multi-target drug discovery and repurposing
Tianduanyi Wang, Otto Pulkkinen, Tero Aittokallio
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17

Showing 17 citing articles:

Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment
Tomasz M. Wróbel, Flemming Steen Jørgensen, Amit V. Pandey, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6542-6566
Open Access | Times Cited: 26
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Assessments of protodioscin’s antinociceptive and antidiarrheal properties: in vivo and in silico investigations on macromolecule binding affinity and modulatory effects
Pompa Rani Ghosh, Md. Sakib Al Hasan, Razina Rouf, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
PMF-CPI: assessing drug selectivity with a pretrained multi-functional model for compound–protein interactions
Nan Song, Ruihan Dong, Yuqian Pu, et al.
Journal of Cheminformatics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective
Edgar López‐López, José L. Medina‐Franco
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104046-104046
Closed Access | Times Cited: 7
The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment
Monika Maciąg, Vardan T. Karamyan
Journal of Medicinal Chemistry (2025)
Open Access
FEP Protocol Builder: Optimization of Free Energy Perturbation Protocols Using Active Learning
César de Oliveira, Karl Leswing, Shulu Feng, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5592-5603
Closed Access | Times Cited: 9
Leveraging nitrogen occurrence in approved drugs to identify structural patterns
Vijay H. Masand, Sami A. Al‐Hussain, Abdullah Yahya Abdullah Alzahrani, et al.
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 1, pp. 111-124
Closed Access | Times Cited: 7
Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting
Ian R Outhwaite, Sukrit Singh, Benedict‐Tilman Berger, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 6
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells
Paschalis Athanasiadis, Balaguru Ravikumar, Richard Elliott, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107209-107209
Open Access | Times Cited: 4
In silico studies for improving target selectivity of anti-malarial dual falcipain inhibitors vis-à-vis human cathepsins
Jeevan Patra, Smriti Arora, Utsab Debnath, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-20
Closed Access | Times Cited: 1
Validation guidelines for drug-target prediction methods
Ziaurrehman Tanoli, Aron Schulman, Tero Aittokallio
Expert Opinion on Drug Discovery (2024), pp. 1-15
Open Access
Protodioscin exerts antagonistic analgesic and antidiarrheal properties through the cyclooxygenase and µ-opioid receptor interaction pathways
Md. Sakib Al Hasan, Raihan Chowdhury, Pompa Rani Ghosh, et al.
Research Square (Research Square) (2024)
Open Access
TargetSA: Adaptive Simulated Annealing for Target-Specific Drug Design
Zhe Xue, Chenwei Sun, Wenhao Zheng, et al.
Bioinformatics (2024)
Open Access
Advancements in Rational Multi‐Targeted Drug Discovery
Balaguru Ravikumar, Anna Cichońska, Navriti Sahni, et al.
(2024), pp. 109-125
Closed Access
Death by a Thousand Cuts – Combining Kinase Inhibitors for Selective Target Inhibition and Rational Polypharmacology
Ian R Outhwaite, Sukrit Singh, Benedict‐Tilman Berger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
FEP Protocol Builder: Optimization of Free Energy Perturbation Protocols using Active Learning
César de Oliveira, Karl Leswing, Shulu Feng, et al.
(2023)
Open Access
Page 1

Scroll to top